A Phase I Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and Safety After Administration of NVP-2002 and Co-administration of NVP-2002-R1 and NVP-2002-R2 in Healthy Adult Volunteers
Latest Information Update: 09 Oct 2023
At a glance
- Drugs NVP-2002 (Primary) ; NVP-2002-R1 (Primary) ; NVP-2002-R2 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Navipharm
- 03 Oct 2023 Status changed from active, no longer recruiting to completed.
- 05 Jan 2023 Planned primary completion date changed from 1 Mar 2023 to 28 Feb 2023.
- 05 Jan 2023 Status changed from not yet recruiting to active, no longer recruiting.